A new potential therapy for COVID-19 developed by researchers at Rush University Medical Center has shown success in preventing the disease’s symptoms in mice.
The race is on to create natural biocompatible piezoelectric materials for energy harvesting, electronic sensing, and stimulating nerves. Researchers decided to explore peptide-based nanotubes, and in the Journal of Applied Physics, they report using a combination of ultraviolet and ozone exposure to generate a wettability difference and an applied field to create horizontally aligned polarization of nanotubes on flexible substrates with interlocking electrodes. The group’s work will enable the use of organic materials more widely.
Danforth Center scientists, Dilip Shah, PhD, Siva Velivelli, PhD, Kirk Czymmek, PhD, and their collaborators at the Pacific Northwest National Laboratory have identified a sub class of peptides in the nodules of the legume, Medicago truncatula that proved effective in inhibiting growth of the fungus causing gray mold.
Scientists at Berkeley Lab and Stanford have joined forces to aim a gene-targeting, antiviral agent called PAC-MAN against COVID-19.
A UC Davis research team, led by Vladimir Yarov-Yarovoy and Heike Wulff, will receive a $1.5 million grant from the National Institutes of Health (NIH) to develop a novel class of peptides that are better at treating pain and don’t have the side effects of opioids. The grant is part of the NIH initiative Helping to End Addiction Long-Term (HEAL Initiative).